2009
DOI: 10.1186/1471-244x-9-26
|View full text |Cite
|
Sign up to set email alerts
|

The self-reported Montgomery-Åsberg depression rating scale is a useful evaluative tool in major depressive disorder

Abstract: BackgroundThe use of Patient-reported Outcomes (PROs) as secondary endpoints in the development of new antidepressants has grown in recent years. The objective of this study was to assess the psychometric properties of the 9-item, patient-administered version of the Montgomery-Åsberg Depression Rating Scale (MADRS-S).MethodsData from a multicentre, double-blind, 8-week, randomised controlled trial of 278 outpatients diagnosed with Major Depressive Disorder were used to evaluate the validity, reliability and se… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
128
1
4

Year Published

2012
2012
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 152 publications
(136 citation statements)
references
References 22 publications
3
128
1
4
Order By: Relevance
“…[3] Another study concluded that patients accepted MADRS-S as a complement to the physician-administered version of the scale and that MADRS-S was clinically valuable and valid for use in clinical practice and research. [10] Satisfactory correspondence between MADRS-S and Beck Depression Inventory II has also been demonstrated.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…[3] Another study concluded that patients accepted MADRS-S as a complement to the physician-administered version of the scale and that MADRS-S was clinically valuable and valid for use in clinical practice and research. [10] Satisfactory correspondence between MADRS-S and Beck Depression Inventory II has also been demonstrated.…”
Section: Methodsmentioning
confidence: 99%
“…Many such scales exist, but the Montgomery-Asberg Depression Rating Scale (self-rating version) (MADRS-S) is the most commonly used in Sweden. [2] Studies indicate that routine assessments of patients’ depressive symptoms in clinical practice are beneficial;[1] they can help GPs evaluate the progress of depression,[3] and can facilitate cooperation and communication between the GP and the patient Communication is of great importance during the consultation and this benefits patients in many ways, including increasing satisfaction with care and improving patients’ understanding of and knowledge about their condition. [4,5] However, according to a systematic review on “Diagnosis and follow up of affective disorders”,[1] there are no studies of acceptable quality that compare rating scales to assess severity of depression against an adequate reference standard, why the review asserts that there is no evidence to support their use to monitor depression severity during treatment.…”
Section: Introductionmentioning
confidence: 99%
“…(Note that the MADRS-S is sometimes rated on a zero to six with no half-steps, e.g., Svanborg & Ekselius [2003]. The scale has been reported to possess good psychometric properties, with a test-retest reliability of .78 and an internal consistency (Cronbach's alpha) of .84 (Fantino & Moore, 2009). Svanborg and Åsberg (2001) reported a mean score of 14.5 (SD=4.7) for patients with a diagnosis of major depression, whereas those in full remission had a mean score of 1.7 (SD=0.8).…”
Section: Methodsmentioning
confidence: 99%
“…It is a self-reported scale based on evaluations of the past three days regarding nine issues: mood, feelings of unease, sleep, appetite, ability to concentrate, initiative, emotional involvement, pessimism and zest for life on seven-point scales (range 0-6 individual items, total range 0-54) [36][37][38]. The consistency of the MADRS-S is satisfactory with Cronbach's alpha 0.84 [38]. As sleep disturbance is an important feature the item 'sleep' in the MADRS-S instrument, it will be analyzed separately.…”
Section: Psychometric Datamentioning
confidence: 99%